JAMA Netw Open
More precise allergy alerts shift antibiotic use

Clinical takeaway: For patients with an untested penicillin allergy label, a risk-stratified electronic health record alert may help clinicians use cephalosporins more often while reducing unnecessary alerts. The findings support updating alert systems to reflect current evidence on cross-reactivity, while retaining safeguards for higher-risk allergy histories.
Penicillin allergy labels can steer clinicians away from cephalosporins, which are often first-line antibiotics. Updated practice parameters support risk-stratified use, but electronic health record alerts may still flag any cephalosporin for anyone with a penicillin allergy label.
After a revised alert system was introduced at Vanderbilt University Medical Center, weekly cephalosporin use increased by 17.8% among inpatients, 35.4% in the operating room, and 16.7% in outpatient care. Among hospitalized patients with penicillin allergy labels, use of fluoroquinolones fell by 12.5% and clindamycin by 34.5%; carbapenem and metronidazole use did not change significantly.
The updated system reduced cross-reactivity alerts by 86%, from an average of 715 to 102 per week. Researchers found no anaphylaxis among patients given cephalosporins under the new alert scheme, based on a review of epinephrine administrations within an hour of exposure. Longer-term effects on outcomes such as surgical site infections and readmissions remain unknown.
The quality improvement study included 26,903 patients with penicillin allergy labels in Vanderbilt’s health system. Researchers compared antibiotic use and alert frequency before and after revising the electronic health record alerts to account for allergy risk and known cross-reactivity patterns.
Updating these alerts could help health systems reduce avoidable barriers to first-line antibiotic use while preserving warnings for patients whose allergy history warrants caution. Further evaluation will show whether the shift in prescribing also improves clinical outcomes over time.
“The impacts that we have observed appear to safely promote key goals of antimicrobial stewardship toward use of first-line and narrow-spectrum antibiotics,” the authors wrote.
Source: Stone CA Jr, et al. (2026 Nov 13) JAMA Netw Open. Penicillin-Cephalosporin Cross-Reactivity Alert Modifications and Cephalosporin Use Among Patients With Untested Penicillin Allergy Labels